Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
Cure Today1d
Real-World Data Confirms Safety of Bavencio and Inlyta in Advanced RCC
In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...
mskcc.org2d
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumor (TGCT)
The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...
FiercePharma3d
Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA
Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...